NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/14/2026
Back to search
Official data from USPTO
BIVICTRIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
05/15/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
02/22/2022
Registration date
08/19/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2025
Last transaction
05/15/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
KOVALSKY, LAURA G
Law office
M10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
BIVICTRIX LIMITED
Representatives
Leon R. Legleiter KDW Firm PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations, namely, preparations for the treatment of cancer; medical preparations, namely, preparations for the treatment of cancer; veterinary preparations, namely, preparations for the treatment of cancer; anti-cancer drugs; anti-cancer preparations of chemical origin; anti-cancer preparations of plant origin; biological preparations for medical purposes, namely, for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of cancer; biotechnological preparations for medical use for the treatment of cancer; chemical preparations for medical purposes, namely, for prevention or treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for prevention or treatment of cancer; chemical preparations for pharmaceutical use, namely, for prevention or treatment of cancer; chemotherapeutics; pharmaceutical compounds for treating cancer; drugs for medical purposes for the treatment of cancer; medicines, namely, medicines for cancer disorders; medicines for human purposes, namely, cancer medicines; pharmaceutical compositions, namely, preparations for the treatment of cancer; pharmaceutical drugs, namely, preparations for the treatment of cancer; pharmaceutical preparations and substances, namely, preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human use, namely, preparations for the treatment of cancer; pharmaceutical preparations for medical purposes, namely, preparations for the treatment of cancer; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer
Publications
History of USPTO decisions and trademark events.
40 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/12/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/25/2026
FIMP
FINAL DISPOSITION PROCESSED
02/25/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/19/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/19/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/19/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/03/2025
PUBO
PUBLISHED FOR OPPOSITION
06/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/28/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/30/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
04/30/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/30/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
04/30/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/30/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/28/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/28/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/28/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/30/2024
GNFR
FINAL REFUSAL E-MAILED
09/30/2024
CNFR
FINAL REFUSAL WRITTEN
09/30/2024
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
04/02/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/07/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/20/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/20/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/02/2023
GNSL
LETTER OF SUSPENSION E-MAILED
10/02/2023
CNSL
SUSPENSION LETTER WRITTEN
10/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/21/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/15/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/15/2023
RFNT
REFUSAL PROCESSED BY IB
03/06/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/15/2023
RFRR
REFUSAL PROCESSED BY MPU
02/15/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/20/2022
CNRT
NON-FINAL ACTION WRITTEN
12/19/2022
DOCK
ASSIGNED TO EXAMINER
12/06/2022
MAFR
APPLICATION FILING RECEIPT MAILED
07/19/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/15/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/14/2022
Continuous trademark protection
Get notified about every new filing that threatens BIVICTRIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.